el-Naggar A K, Ro J Y, McLemore D, Garnsy L
Department of Pathology, University of Texas, M.D. Anderson Cancer Center, Houston 77030.
Am J Clin Pathol. 1990 Apr;93(4):480-5. doi: 10.1093/ajcp/93.4.480.
Predicting the biologic behavior of cystosarcoma phyllodes of the breast by histopathologic examination has been difficult. Flow cytometric DNA and cell cycle analysis was performed for 30 patients with cystosarcoma phyllodes of the breast to determine its potential prognostic utility. Traditional histopathologic parameters and the patients' clinical outcome with a minimum follow-up period of at least five years were also analyzed. Of all the variables examined, DNA ploidy, proliferative index, number of mitoses, and tumor margin were significantly associated with an adverse clinical course. Multivariate regression analysis of the authors' data showed that DNA content was a significant predictor of the patients' clinical outcome. The authors conclude that the DNA ploidy study is a useful, objective adjunct to the clinicopathologic assessment of cystosarcoma phyllodes of the breast.
通过组织病理学检查预测乳腺叶状囊肉瘤的生物学行为一直很困难。对30例乳腺叶状囊肉瘤患者进行了流式细胞术DNA和细胞周期分析,以确定其潜在的预后价值。还分析了传统组织病理学参数以及随访期至少为五年的患者临床结局。在所有检测的变量中,DNA倍体、增殖指数、有丝分裂数和肿瘤边缘与不良临床病程显著相关。作者对数据进行的多变量回归分析表明,DNA含量是患者临床结局的重要预测指标。作者得出结论,DNA倍体研究是乳腺叶状囊肉瘤临床病理评估中有用的、客观的辅助手段。